Frontline therapy in primary mediastinal B-cell lymphoma: when salvage outcomes redefine the meaning of intensity. Comment on: Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R | Synapse
March 1, 2026Open Access
Frontline therapy in primary mediastinal B-cell lymphoma: when salvage outcomes redefine the meaning of intensity. Comment on: Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R
Key Points
The aim is to explore the implications of salvage therapy outcomes in patients with primary mediastinal B-cell lymphoma following frontline treatment.
Review of existing literature on frontline DA-EPOCH-R therapy.
Analysis of salvage therapy outcomes in relapsed or refractory cases.
Salvage outcomes show improved survival rates compared to previous treatments.
Intensity of salvage interventions appears to influence patient prognosis.